[HTML][HTML] Relative efficacy and safety of inhaled corticosteroids in patients with asthma: systematic review and network meta-analysis

B Chipps, B Taylor, V Bayer, A Shaikh… - Annals of Allergy …, 2020 - Elsevier
Background Inhaled corticosteroids (ICSs) are recommended as first-line controller medications
for persistent asthma. However, guidelines on the initial ICS doses, step-up and step-…

The safety of long-term use of inhaled corticosteroids in patients with asthma: a systematic review and meta-analysis

W Shang, G Wang, Y Wang, D Han - Clinical Immunology, 2022 - Elsevier
Inhaled corticosteroids (ICS) are the treatment of choice for long-term asthma control in
both adults and children [3]. Long-term regular use of ICS alone or in combination with long-…

Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma–COPD overlap: a systematic review and meta-analysis

JE Amegadzie, J Gorgui, L Acheampong… - Journal of …, 2021 - Taylor & Francis
… In order to identify the totality of evidence for both the effectiveness and safety of inhaled
corticosteroids and long-acting bronchodilators within the context of ACO, we included both …

Effectiveness and safety of inhaled corticosteroids in older individuals with chronic obstructive pulmonary disease and/or asthma. A population study

T Kendzerska, SD Aaron, T To, C Licskai… - Annals of the …, 2019 - atsjournals.org
… Keywords: COPD; asthma; inhaled corticosteroids; effectiveness; safety Inhaled corticosteroids
(ICS) are established medications for the management of both asthma and chronic …

Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety

D Price, M Castro, A Bourdin, S Fucile… - European Respiratory …, 2020 - Eur Respiratory Soc
… to inhaled medication (inhaled corticosteroids; ICS) and incorrect use of inhalers. In addition,
patients with asthma may use SCS not only for asthma but also for frequently associated …

Comparisons of efficacy and safety between triple (inhaled corticosteroid/long-acting muscarinic antagonist/long-acting beta-agonist) therapies in chronic obstructive …

HW Lee, HJ Kim, EJ Jang, CH Lee - Respiration, 2021 - karger.com
Background: Various combinations of inhaled corticosteroid (ICS), long-acting muscarinic
antagonist (LAMA), and long-acting beta-agonist (LABA) have been used as triple therapy for …

[HTML][HTML] Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD …

J Zheng, S Baldi, L Zhao, H Li, KH Lee, D Singh… - Respiratory …, 2021 - Springer
… This study evaluated the efficacy and safety of BDP/FF/G in patients in three eastern Asian
… We therefore evaluated the efficacy and safety of BDP/FF/G in patients with COPD in three …

Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment

MG Matera, B Rinaldi, L Calzetta, P Rogliani… - Pulmonary …, 2019 - Elsevier
… The differences in the pharmacokinetic (PK) characteristics of inhaled corticosteroids (ICSs)
critically influence the profile of each of them, but also the significant differences in …

[HTML][HTML] Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease

C Janson - Journal of Thoracic Disease, 2020 - ncbi.nlm.nih.gov
… In chronic obstructive pulmonary disease (COPD), treatment with inhaled corticosteroids (…
in COPD and to compare the effectiveness and safety of different ICSs. Studies comparing the …

[HTML][HTML] Efficacy and safety of inhaled ciclesonide in treating patients with asymptomatic or mild COVID-19 in the RACCO trial: protocol for a multicenter, open-label …

J Terada-Hirashima, M Suzuki… - JMIR research …, 2020 - researchprotocols.org
… The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting
viral NSP15. bioRxiv Preprint posted online on March 12, 2020 [FREE Full text] [CrossRef] …